We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
29 hedge funds and large institutions have $37.1M invested in Interpace Biosciences, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
2% less capital invested
Capital invested by funds: $37.9M → $37.1M (-$780K)
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
34% less funds holding
Funds holding: 44 → 29 (-15)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 15
Holders
29
Holders Change
-15
Holders Change %
-34.09%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
9
Reduced
11
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
RA
Royce & Associates
New York
|
-$1.08M |
| 2 |
KSC
Kendall Square Capital
San Francisco,
California
|
-$669K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$354K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$205K |
| 5 |
CI
Cowen Inc
New York
|
-$163K |
